Rempex Pharmaceuticals preclinical data

In a multi-drug resistant isolate panel of Enterobacteriaceae, the minimum inhibitory concentration with antimicrobial activity against 90% of the isolates (MIC90) was 0.5 µg/mL for Carbavance vs. >32...